NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)
NT trends in ecstasy and related drug markets; Reports; PublicationNT
Made available via the Publications (Legal Deposit) Act 2004 (NT).
Date:2011; Australian drug trends series No. 80
Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals
National Drug and Alcohol Research Centre, University of New South Wales
Check within Publication or with content Publisher.
81 Health KE 5 The number of clients with psychiatric presentations remain stable with no apparent increase or decrease over the past 12 months. Most clients present with some mental health problems, generally anxiety and depression. Health KE 6 Anxiety is most common and more clients present with anxiety than depression although there are certainly some with depression. Access to psychologists is difficult and needs to be through a GP. There are also cost issues. Concurrent use of benzodiazepines and cannabis leads to significant memory problems. Health KE 7 Anxiety is most common, often in combination with depression. PTSD is also seen. Health KE 8 We are seeing more people presenting with anxiety and depression but this may be due to better assessment associated with employing a psychiatric registrar. 6.6 Driving risk behaviour Fifty-five percent of the IDRS sample had driven a car within the six months prior to interview and, of those, 15% had driven under the influence of alcohol during this period. Of the group who had driven under the influence of alcohol, 38% reported driving over the legal blood alcohol limit, on a median of 12 occasions. Seventy-six percent of drivers reported that within the six months prior to interview they had driven under the influence of illicit drugs, on a median of 50 (range 1 to 200) times, within a median of 30 minutes after taking the drugs. Figure 50 illustrates that morphine (66%) and cannabis (39%) were the drugs most commonly consumed by drivers, followed by speed powder (15%), benzodiazepines (10%), ice (7%), base methamphetamine (2%), methadone (2%) and heroin (2%). The illicit drugs consumed prior to the last occasion of driving under the influence were identified as morphine (72%), cannabis (19%), methamphetamine powder (16%), benzodiazepines (7%), other opiates (2%), methadone (2%), Suboxone (2%), ecstasy (2%) and other drugs (2%).